SCHEMBL30212445

SCHEMBL30212445

CC(C)(c1ccc(Oc2ccnc(Cl)c2)cc1)c1ccc(OC2CCC2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACACB O00763 1/20 0.37
MAPT P10636 3/20 0.35
FDPS P14324 2/20 0.35
LMNA P02545 1/20 0.35
BRAF P15056 5/20 0.33
KDR P35968 5/20 0.33
PARP10 Q53GL7 1/20 0.33
TP53 P04637 2/20 0.33
HPGD P15428 2/20 0.33
TSHR P16473 2/20 0.33
MEN1 O00255 1/20 0.33
CYP1A2 P05177 1/20 0.33
KMT2A Q03164 1/20 0.33
ALDH1A1 P00352 1/20 0.33
PPARG P37231 1/20 0.33
HIF1A Q16665 1/20 0.33
P2RX3 P56373 2/20 0.33
DDR2 Q16832 1/20 0.33
FGFR2 P21802 1/20 0.32
LNPEP Q9UIQ6 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17396860 0.80 LOX (0.40) FDPSPARP10LNPEP
SCHEMBL27234155 0.80 P2RX3 (0.37) BRAFKDRPPARGP2RX3LNPEP
SCHEMBL27234162 0.80 P2RX3 (0.37) BRAFKDRPPARGP2RX3LNPEP
SCHEMBL30212469 0.78 BTK (0.38) BRAFKDRKMT2AP2RX3
SCHEMBL24921975 0.77 ACACB (0.38) ACACBMAPTLMNAPARP10TP53
SCHEMBL24922619 0.77 ACACB (0.40) ACACBMAPTLMNAPARP10TP53
SCHEMBL24921910 0.77 LMNA (0.38) ACACBMAPTLMNATP53HPGD
SCHEMBL30212532 0.76 ACACB (0.40) ACACBMAPTLMNAPARP10TP53
SCHEMBL190777 0.75 LOX (0.45) FDPSHPGDLNPEP
SCHEMBL24921453 0.75 CHRNB2 (0.39) ACACBMAPTLMNAPARP10TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023006097-A1 BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUND AND USE THEREOF AS ANDROGEN RECEPTOR DEGRADER 海创药业股份有限公司 2023-02-02 WO disclosed